Avagenesis Corp. — Investor Relations & Filings

Avagenesis Corp. is a biotechnology company specializing in the development and commercialization of automated bioprocessing and cell-isolation technologies. The company focuses on creating a standardized platform for the efficient isolation and enrichment of regenerative cells, primarily adipose stem cells, from human adipose tissue. This proprietary technology is designed to produce a highly potent regenerative biopharmaceutical product. Avagenesis targets premium medical markets, including applications in cosmetic and aesthetic medicine, burn management, and general regenerative therapy research. The company maintains quality standards, holding ISO 13485 and 9001 certifications for its cell isolation system.